Taysha Gene Therapies Balance Sheet (2019-2026) | TSHA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Accumulated Depreciation (Quarter)	0.13M	0.29M	0.50M	0.75M	1.02M	1.29M	1.64M	1.97M	2.31M	2.64M	2.98M	3.31M	3.63M	3.91M	3.58M	3.82M	4.10M	4.38M	4.68M	4.97M
Assets
Current Assets
Cash & Equivalents (Quarter)	197.37M	188.78M	151.74M	99.27M	68.88M	34.31M		63.42M	45.08M	164.28M	142.40M	123.98M	172.74M	157.69M	138.30M	116.59M	312.76M	297.34M	319.77M	276.58M
Receivables - Other (Quarter)		2.60M	2.60M	2.60M	2.60M	2.60M	2.60M	2.60M	2.60M	2.60M	2.60M	2.60M	2.60M	2.60M	2.60M	2.60M	2.60M	2.60M	2.60M	2.60M
Prepaid Assets (Quarter)	1.01M	8.38M	10.50M	0.12M	0.68M	8.70M	8.54M	0.37M	0.33M	0.34M	3.48M	0.27M	0.17M	3.42M	0.25M	0.23M	0.24M	0.05M	0.11M	5.22M
Current Assets (Quarter)	207.30M	197.17M	159.60M	106.89M	76.83M	43.00M	96.42M	72.36M	54.12M	171.81M	149.87M	130.60M	178.47M	161.56M	142.13M	120.71M	316.26M	299.95M	324.65M	282.25M
Non-Current Assets
Construction in Progress (Quarter)	30.30M	0.04M		3.00M	56.30M	59.00M
Property, Plant & Equipment (Net) (Quarter)	33.87M	40.55M	50.61M	55.12M	61.01M	63.95M	14.96M	14.64M	14.14M	11.17M	10.83M	10.69M	10.51M	7.61M	7.49M	7.24M	6.96M	6.80M	6.74M	6.45M
Other Non-Current Assets (Quarter)		2.63M	2.64M	2.64M	2.64M	2.64M	2.64M	2.64M	2.64M	2.64M	2.60M	2.60M	2.60M	2.60M	0.22M	2.60M	2.15M	0.18M	2.31M	2.76M
Non-Current Assets (Quarter)	34.56M	43.87M		59.09M	65.50M	68.47M		29.24M	27.43M	23.96M		22.40M	21.92M	18.66M		17.65M	17.07M	16.60M		18.10M
Assets (Quarter)	241.86M	241.04M	213.96M	165.98M	142.33M	111.47M	126.28M	101.60M	81.54M	195.77M	172.73M	153.00M	200.39M	180.22M	160.36M	138.36M	333.33M	316.55M	343.32M	300.35M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	6.36M	22.05M	21.76M	22.00M	23.97M	15.25M	10.95M	9.00M	10.77M	7.52M	6.37M	10.38M	8.72M	4.93M	3.59M	4.33M	7.71M	5.44M	6.28M	4.56M
Payables (Quarter)	6.36M	22.05M	21.76M	22.00M	23.97M	15.25M	10.95M	9.00M	10.77M	7.52M	6.37M	10.38M	8.72M	4.93M	3.59M	4.33M	7.71M	5.44M	6.28M	4.56M
Accumulated Expenses (Quarter)	14.51M	9.33M	29.98M	2.18M	18.99M	17.89M	2.52M	6.45M	19.63M	2.75M	3.42M	13.56M	2.88M	3.89M	5.24M	10.76M	12.15M	17.71M	9.43M	15.53M
Other Accumulated Expenses (Quarter)	0.68M	0.78M	1.49M	1.59M	1.48M	1.58M	0.65M	0.69M	0.68M	0.68M	0.72M	0.78M	0.78M	0.88M	0.75M	0.81M	0.80M	0.75M	0.78M	0.78M
Short term Debt (Quarter)										140.53M
Current Leases (Quarter)							1.52M	1.75M	1.64M	1.54M	1.65M	1.70M	1.75M	1.81M	1.88M	1.81M	1.74M	1.67M	1.86M	1.82M
Current Deferred Revenue (Quarter)							33.56M	28.90M	20.20M	18.76M	18.11M	14.70M	13.58M	11.80M	9.77M	7.47M	5.49M	5.49M
Total Current Liabilities (Quarter)	28.39M	43.21M	51.75M	48.62M	42.95M	33.14M	62.79M	54.45M	50.64M	180.45M	36.76M	38.64M	34.18M	29.34M	26.23M	22.56M	25.35M	28.63M	26.55M	20.10M
Non-Current Liabilities
Non-Current Debt (Quarter)		27.81M	37.19M	37.39M	37.58M	37.77M	37.97M	38.16M	38.35M	38.55M	40.51M	40.51M	37.84M	42.97M	43.94M	42.45M	41.05M	50.85M	50.11M	48.96M
Non-Current Deffered Revenue (Quarter)									6.20M	2.95M
Operating Leases (Quarter)							20.44M	19.93M	19.53M	19.10M	18.95M	18.50M	18.13M	17.75M	17.36M	17.09M	16.81M	16.51M	18.17M	17.77M
Other Non-Current Liabilities (Quarter)	0.77M	3.02M	3.73M	3.50M	3.48M	3.93M	4.13M	4.00M	3.92M	3.83M	1.58M	42.13M	39.23M	1.36M	1.31M	1.20M	1.40M	1.58M	1.55M	1.58M
Total Non-Current Liabilities (Quarter)	54.60M	97.63M	114.84M	111.75M	106.14M	96.41M	121.20M	112.54M	114.73M	241.05M	96.22M	57.02M	52.29M	90.06M	87.53M	82.10M	83.21M	95.99M	94.83M	86.83M
Total Liabilities (Quarter)	55.37M	100.65M	118.57M	115.25M	109.62M	100.34M	125.33M	116.55M	118.66M	244.88M	97.79M	99.15M	91.53M	91.42M	88.84M	83.30M	84.60M	97.56M	96.38M	88.41M
Shareholder's Equity
Total Debt (Quarter)		27.81M	37.19M	37.39M	37.58M	37.77M	37.97M	38.16M	38.35M	179.08M	40.51M	40.51M	37.84M	42.97M	43.94M	42.45M	41.05M	50.85M	50.11M	48.96M
Common Equity (Quarter)	186.50M	140.39M	95.38M	50.74M	32.51M	10.70M	0.95M	-14.95M	-37.11M	-49.11M	74.94M	53.85M	108.87M	88.80M	71.53M	55.06M	248.73M	218.99M	246.94M	211.94M
Shareholder's Equity (Quarter)	186.50M	140.39M	95.38M	50.74M	32.51M	10.70M	0.95M	-14.95M	-37.11M	-49.11M	74.94M	53.85M	108.87M	88.80M	71.53M	55.06M	248.73M	218.99M	246.94M	211.94M
Liabilities and Shareholders Equity (Quarter)	241.86M	241.04M	213.96M	165.98M	142.33M	111.47M	126.28M	101.60M	81.54M	195.77M	172.73M	153.00M	200.39M	180.22M	160.36M	138.36M	333.33M	316.55M	343.32M	300.35M
Retained Earnings (Quarter)	-134.10M	-185.26M	-235.65M	-285.80M	-319.63M	-345.94M	-401.44M	-419.06M	-443.66M	-560.70M	-513.01M	-0.25M	-558.00M	-583.52M	-602.30M	-2.29M	-0.70M	-1.14M	-711.30M	-753.71M
Treasury Shares (Quarter)	0.47M	1.89M	1.89M	1.89M	1.34M	0.15M	1.26M	0.07M	0.46M	0.38M	0.38M			4.55M	4.55M	6.24M	6.27M	6.27M	6.31M	10.88M
Shares Outstanding (Quarter)	38.39M	38.47M	38.47M	38.47M	41.02M	41.18M	63.21M	63.47M	64.43M	186.96M	186.96M	187.02M	201.38M	204.94M	204.94M	205.05M	272.73M	273.92M	285.05M	287.28M

Research Tools

Developers

Taysha Gene Therapies Balance Sheet (2019-2026) | TSHA

Research Tools

Developers

Taysha Gene Therapies Balance Sheet (2019-2026) | TSHA

Create an account

Sign In

Reset Password